Tag: Sexually Transmitted Diseases: AIDS/HIV
Decrease Seen in HIV Testing, Diagnoses During Pandemic
Decreases seen in priority populations including Black gay men, Hispanic gay men, bisexual men, MSM, transgender persons
In AIDS-Related Lymphoma, Outcomes Worse With Hypoalbuminemia
AIDS-related lymphoma patients with hypoalbuminemia show worse overall survival, two-year progression-free survival
Treating Anal HSIL Cuts Anal Cancer Risk in Persons With HIV
Rate of progression to anal cancer lower for those receiving treatment of anal high-grade squamous intraepithelial lesions
Risk for SARS-CoV-2 Breakthrough Infections Up in Persons With HIV
Risk for breakthrough infections increased in association with younger age, history of COVID-19, not receiving additional vaccine dose
Lenacapavir Reduces Viral Load in Multidrug-Resistant HIV-1 Infection
Reduction in viral load from baseline greater with lenacapavir versus placebo among those with multidrug-resistant HIV-1 infection
FDA Approves Marketing of First Condom Designed for Anal Sex
Condom was approved through the De Novo premarket review pathway for low- to moderate-risk devices of a new type
Woman Cured of HIV After Umbilical Cord Blood Transplant
Cord blood contained a mutation that blocks HIV entry into cells and came from a partially matched donor
First Shots Given in Trial of Moderna mRNA-Based HIV Vaccine
Vaccine uses mRNA technology to deliver HIV-specific antigens that could trigger an immune response against the virus
Long-Acting Cabotegravir Not Necessarily Cost-Effective for PrEP
Benefits do not necessarily justify large price difference compared with generic F/TDF for men who have sex with men and transgender women
Dolutegravir-Based ART Superior for Children, Teens With HIV
Rate of serious adverse events similar for participants receiving dolutegravir, standard care as first-, second-line treatment for HIV-1 infection
